Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2018 August;70(4) > Minerva Ginecologica 2018 August;70(4):415-23

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  FERTILITY PRESERVATION IN WOMEN 

Minerva Ginecologica 2018 August;70(4):415-23

DOI: 10.23736/S0026-4784.18.04218-1

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Vitrification of human oocytes

Aila COELLO, Antonio PELLICER, Ana COBO

Instituto Valenciano de Infertilidad, University of Valencia, Valencia, Spain


PDF


In recent years, growing evidence for the safety and efficiency of oocyte vitrification has made this technique be increasingly proposed for fertility preservation (FP). The populations who could benefit from FP include oncological patients who need the option to preserve their gametes before undergoing potential sterilizing treatment, patients with non-oncologic conditions requiring gonadotoxic chemotherapy and women who wish to delay their motherhood for a variety of reasons. By vitrifying oocytes, women have the chance to conceive in the future, have their own genetic offspring and maintain their reproductive autonomy. This review focuses on describing current knowledge on oocyte vitrification as a means to preserve female fertility. We present the general experience of our group and others in FP for both oncological and non-oncological reasons.


KEY WORDS: Vitrification - Oocytes - In-vitro oocyte maturation techniques - Fertility preservation - Cryopreservation - Neoplasms

top of page